Companies / Dermata Therapeutics, Inc. / Activity
Activity — Dermata Therapeutics, Inc.
12 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Bedoya-Toro Munera Maria E Executive | Buy | Common Stock | $1.3K | +1K +8333.33% | 1,012 0.03% of shares | low |
| Jan 2, 2026 | Van Hoose Kyri K. Executive | Grant | Stock Option (right to buy) | — | +18K | 18,000 0.45% of shares | low |
| Jan 2, 2026 | Nardo Christopher J. Executive | Grant | Stock Option (right to buy) | — | +18K | 18,000 0.45% of shares | low |
| Jan 2, 2026 | Bradrick Brittany Director | Grant | Stock Option (Right to Buy) | — | +3K | 2,500 0.06% of shares | low |
| Jan 2, 2026 | Scott Kathleen D. Director | Grant | Stock Option (Right to Buy) | — | +3K | 2,500 0.06% of shares | low |
| Jan 2, 2026 | Sandler Andrew Seth Director | Grant | Stock Option (Right to Buy) | — | +3K | 2,500 0.06% of shares | low |
| Jan 2, 2026 | Bedoya-Toro Munera Maria E Executive | Grant | Stock Option (right to buy) | — | +9K | 9,000 0.22% of shares | low |
| Jan 2, 2026 | Mento Steven J Director | Grant | Stock Option (Right to Buy) | — | +3K | 2,500 0.06% of shares | low |
| Jan 2, 2026 | Proehl Gerald T CEO | Grant | Stock Option (right to buy) | — | +38K | 37,500 0.93% of shares | low |
| Jan 2, 2026 | Fisher Mary Director | Grant | Stock Option (Right to Buy) | — | +3K | 2,500 0.06% of shares | low |
| Jan 2, 2026 | Wierenga Wendell Director | Grant | Stock Option (Right to Buy) | — | +3K | 2,500 0.06% of shares | low |
| Jan 2, 2026 | Hale David F Director | Grant | Stock Option (Right to Buy) | — | +3K | 2,500 0.06% of shares | low |